Article has an altmetric score of 1

(±)-BIGI-3h: Pentatarget-Directed Ligand combining Cholinesterase, Monoamine Oxidase, and Glycogen Synthase Kinase 3β Inhibition with Calcium Channel Antagonism and Antiaggregating Properties for Alzheimer's Disease Article

Ismaili, Lhassane, Monnin, Julie, Etievant, Adeline et al. (2021). (±)-BIGI-3h: Pentatarget-Directed Ligand combining Cholinesterase, Monoamine Oxidase, and Glycogen Synthase Kinase 3β Inhibition with Calcium Channel Antagonism and Antiaggregating Properties for Alzheimer's Disease . ACS CHEMICAL NEUROSCIENCE, 12(8), 1328-1342. 10.1021/acschemneuro.0c00803

International Collaboration

cited authors

  • Ismaili, Lhassane; Monnin, Julie; Etievant, Adeline; Arribas, Raquel L; Viejo, Lucia; Refouvelet, Bernard; Soukup, Ondrej; Janockova, Jana; Hepnarova, Vendula; Korabecny, Jan; Kucera, Tomas; Jun, Daniel; Andrys, Rudolf; Musilek, Kamil; Baguet, Aurelie; Garcia-Frutos, Eva M; De Simone, Angela; Andrisano, Vincenza; Bartolini, Manuela; de Los Rios, Cristobal; Marco-Contelles, Jose; Haffen, Emmanuel

sustainable development goals

authors

publication date

  • April 21, 2021

published in

keywords

  • ACETYLCHOLINESTERASE INHIBITORS
  • AGGREGATION
  • ASSAY INTERFERENCE COMPOUNDS
  • Alzheimer's disease
  • Biginelli reaction
  • Biochemistry & Molecular Biology
  • COMPOUNDS PAINS
  • Chemistry, Medicinal
  • DRUG DISCOVERY
  • FLUORESCEIN
  • GSK 3 beta
  • HYBRIDS
  • Life Sciences & Biomedicine
  • MAO
  • Neurosciences
  • Neurosciences & Neurology
  • OXIDATIVE STRESS
  • PEPTIDE
  • Pharmacology & Pharmacy
  • Science & Technology
  • TARGET
  • calcium channel
  • cholinesterases

Digital Object Identifier (DOI)

publisher

  • AMER CHEMICAL SOC

start page

  • 1328

end page

  • 1342

volume

  • 12

issue

  • 8